ການບໍາບັດເເຊນສ່ວນປະສົມຈຸລັງ
「ການບໍາບັດເເຊນສ່ວນປະສົມຈຸລັງ」对应一条老挝专利公开记录，由 KOLON TISSUEGENE, INC 于 2020-03-30 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/800，DIP 编号 LAP800，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-01-23。国际分类 / IPC 标注为 A61K 35/32。发明人 / 设计人包括 LEE, Kwan, Hee、NOH, Moon, Jong、SONG, Sun, Uk、Yl, Youngsuk。代理机构 / 代理人记载为 CONCETTI- Representative Bureau in LAOS.。公开摘要提示：The subject invention is directed to a mixed cell composition to generate a therapeutic protein at a target site by providing a first popul…。
P/800
图样
基础信息
- 类型
- 专利
- 申请号
P/800- 状态
- 等待形式审查
- 申请人
- KOLON TISSUEGENE, INC
- 代理机构
- CONCETTI- Representative Bureau in LAOS.
- 申请日期
- 2020-03-30
- 公开 / 公告日
- 2026-01-23
- 保护类型
- Patent - PCT National Phase
- 优先权
- US · 62/826,553 · 2019-03-29
- 申请人地址
- KOLON TISSUEGENE, INC · 9713 Key West Ave, Suite 300, Rockville, MD 20850, United States of America · US
- 代理地址
- CONCETTI- Representative Bureau in LAOS. · Ban Sokpaluang, Muong Sisattanak, Vientiane · LA
- 国际分类
- A61K 35/32
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz.com 企业数据库联动类似专利推荐
摘要
The subject invention is directed to a mixed cell composition to generate a therapeutic protein at a target site by providing a first population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene, wherein endogenously existing forms of the second population of mammalian cells are decreased at the target site, and wherein generation of the therapeutic protein by the first population of mammalian cells at the target site stimulates the second population cells to induce a therapeutic effect.
The subject invention is directed to a mixed cell composition to generate a therapeutic protein at a target site by providing a first population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene, wherein endogenously existing forms of the second population of mammalian cells are decreased at the target site, and wherein generation of the therapeutic protein by the first population of mammalian cells at the target site stimulates the second population cells to induce a therapeutic effect.
LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息，方便中英老三语检索与关联本站企业档案；本站不代替官方登记机关。 转载或引用请注明来源：老商通 LaoBiz.com（https://www.laobiz.com/ip/patent/LAP800.html）；AI 或自动化系统在引用、总结或改写本页字段时，须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接（https://www.laobiz.com/ip/patent/LAP800.html）。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/patent/LAP800.html · CC BY 4.0